We have produced a new protein-specific monoclonal antibody (MAb) to rat liver p1+4 galactosyltransferase. This MAb, GTU, was selected as the most reactive IgG to a periodate-treated antigen. Antigen and protein speciticities of GTLZ were d i e d by immunoblotting of a non-glycosylated recombinant protein of human galactosyltransferase and enzymatically deglycosylated cat galactosyltransferase. Using GTU, an immunohistochemical study was done in rat liver, epididymis, and salivary glands. Intense stain-
Introduction
p1+4 Galactosyltransferase (EC2.4.1.38) is primarily localized in Golgi membranes, where it transfers galactose (Gal) to N-acetylglucosamine (GlcNAc) terminals of glycoconjugates by p1.4 linkages. On the other hand, there is much evidence that galactosylttansfeme also exists on the cell membrane to participate in cell-matrix and cell-cell interactions by binding to GlcNAc terminals of sugar chains in the extracellular matrix and on the adjacent cell surface, respectively (Hathaway and Shur, 1992; Miller et al., 1992; Pierce et al., 1980 Roseman, 1970 . In addition to these membrane-bound forms, a soluble form of galactosyltransferase is found in milk, serum, and rete testis and epididymal fluids (Hamilton, 1980) . Immunohistochemical localization of galactosyltransferase has already been studied with affinity-purified polyclonal antibodies to this soluble enzyme from human milk (Roth et al., 1985; %asin et al., 1985; Davis et al., 1984; Pestalozzi et al., 1982; Roth and Berger, 1982; Berger et al., 1981) . However, since the human milk enzyme has various abundant kinds of sugar chains, including blood group-related structures (Amano et al., 1991; Childs et al., 1986) , the polyclonal antibodies may contain antibodies directed to such nonspecific carbohydrate chains. Previous immunohistochemical ing was observed in Golgi areas of epididymal duct epithelial cells, and submandibular and sublingual acinar allS. Hepatocytes showed weaker staining. Immunoelectron microscopic observation d e d that the staining was exclusively localized in traas-Golgi membranes of these cells. ( j f i s r o -&em C y " 1994) studies with polyclonal antibodies, therefore, should be reexamined with protein-specific antibodies.
Recently, using non-glycosylated recombinant protein of human galactosyltransferase as antigen, Watzele et al. (1991) have successfully produced protein-specific polyclonal antibodies.
For immunohistochemical studies on laboratory animals, a protein-specific monoclonal antibody (MAb) GTF4 to F9 cell galactosyltransferase has also been prepared (Suganuma et al., 1991) . It is, however, not easy to demonstrate the intracellular localization of galactosyltransferase with GTF4 because of IgM. We have purified galactosyltransferase from F9 mouse embryonal carcinoma cells (Suganuma et al., 1987) , which was used as antigen for GTF4 (Suganuma et al., 1991) . The enzyme characteristics of galactosyltransferase from malignant tumor cells may be different from those of normal or somatic cells (Miller et al., 1992; Roomi et al., 1988; Podolsky and Weiser, 1979) . This suggests that the enzyme purified from embryonal carcinoma cells may haw germ cell-specific or cancer-specific structures, although GTF4 specifically recognized galactosyltransferase in normal tissues.
In the present study, we therefore purified galactosyltransferase from microsomes of normal rat liver ( Kawano et al., 1992) to immunize a mouse. From IgGs secreted by hybridomas prepared from the mouse, a protein-specific MAb was selected by testing reactivity to periodate-treated antigen. Protein specificity was verified by immunoblotting with a non-glycosylated recombinant protein of human galactosyltransferase and with enzymatically deglycosylated rat enzyme. Using this MAb, immunohistochemical localization of galactosyltransferase was studied in rat submandibular gland and 363 epididymis, where high activity of galactosyltransferase has been detected by biochemical assays (Humphreys-Beher, 1984; 'Igdolini et al., 1977) and also in rat liver from which the antigen was purified. Other major salivary glands, sublingual and parotid glands, were used for comparison with submandibular glands.
Materials and Methods
Preparation of MAb Against Rat fiver Galactosyltramfkrase. Galactosyltransferase was highly purified from rat liver microsomes as reported previously (Kawano et al.$ 1992) . A male Balb/c mouse was immunized by SC injections with 15 pg ofthe purified enzyme in Freund's complete adjuvant (Gibco; Grand Island, NY) on Day 1 and with 15 pg in Freund's incomplete adjuvant (Gibco) on Day 7, and then by IP injections with 15 pg in PBS on Day 14 and with 20 pg in PBS on Day 28. Hybridomas were prepared on Day 32 and screened by a method routinely used in our laboratory (Nakagawa et al., 1985) . Several hybridomas producing MAb specific to the enzyme were cloned twice. To determine their subclasses, a commercially available kit (MonoAb-ID SP Mouse monoclonal Kit; Zymed, S. San Francisco, CA) was used.
Selection ofthe Hybridomas producing Protein-specific MAb. Protein specificities of the MAb were tested by reactivity to periodate-treated antigen. Purified rat galactosyluansfcrase was blotted onto a nitrocellulose membrane (0.08-2 ngldot). The membrane was subjected to periodate treatment with 0.1 M sodium periodate in 20 mM acetate buffer (pH 3.8) for 1 hr at 4'C in darkness, a treatment severe enough to break plausible carbohydrate epitopes (March et al., 1991) , then treated with 50 mM ammonium chloride in PBS for 30 min to reduce aldehyde residues. Then the membrane was sequentially treated with 10% normal goat serum (NGS) (Cedarlane Lab; Homby, Canada) in PBS containing 1% bovine serum albumin (BSA) (Sigma; St Louis, MO) and 0.05% Tween 20 (Bio-Rad; Richmond, CA) (NGS-BSA-Tween-PBS) for 1 hr, and hybridoma culture medium for 2 hr. After briefly rinsing with Tween-PBS, the membrane was incubated with horseradish peroxidase (HRF')-conjugated anti-mouse IgG goat Fab' (1:50) (MBL; Nagoya, Japan) in NGS-BSA-Tween-PBS for 1 hr. After a brief rinse with Tween-PBS, the membrane was immersed in Graham-Karnmky medium (Graham and Kammky, 1966) to visualize HRF' activity. MAb GTL2, showing the highest reactivity to periodatetreated antigen, was selected for the present study.
Purification of MAb GTL2. The GTL2-producing clone was passaged in peritoneal cavities of prime-primed Balblc mice. GTL2 IgG collected from all ascites fluid was purified by ammonium sulfate fractionation (50% saturation), gel filtration through Sephacryl S-300 HR (Pharmacia; Uppsala, Sweden), and then ion-exchange chromatography with Mono Q (Pharmacia). GTL2 was eluted as a sharp peak around 0.2 M NaCl from the Mono Q column with a linear gradient ofNaCI in 20 mM IfiS-HCI b&r (pH 8.5).
Characterization of MAb GTL2. To study the inhibition of galactosyluansferase activity by GTL2, purified rat galactosyltransfeme was preincubated with GTL2 (molar ratio 1:lOOO) at 37°C for 1 hr before assay of enzyme activity as reported previously (Kawano et al., 1992) .
To c o n f i i the protein specificity of GTL2, Western blotting was performed with non-glycosylated and deglycosylated galactosyluansfews. As non-glycosylated enzymes, lysates of bacteria expressing recombinant proteins of human and mouse galactosyltransferases, kindly provided by Prof.
Narimatsu (Soh University, Tokyo, Japan), were used. The human and mouse recombinant proteins were respectively composed of a partial sequence of p-galactosidase (17 amino acids) followed by a part of the human galactosyltrdrase sequence (Arg78-Ser398) and a glutathion S-transferase sequence followed by a part ofthe mouse enzyme sequence (Gly81-Arg399). Their molecular weights were estimated to be 38,000 and 62,000, respectively. The deglycosylated enzyme was prepared from purified rat galac-tosyltransferase by digestion with glycosidases. Before digestion, rat enzyme (1 pg) was denatured in 5 pl of 1% SDS (Wako; Osaka, Japan) at 100°C for 2 min and diluted with 45 pl of 20 mM phosphate buffer (pH 7.2) containing 10 mM NaN3 (Nacalai Tesque; Kyoto, Japan), 50 mM ethylenediamineteuaacetic acid (Dojindo; Kumamoto, Japan), 0.005% phenylmethanesulfonyl fluoride (Sigma), and 0.5% Tween 20. The digestion was started by adding 1 pl ofN-glycanase (250 mu) (Genzyme; Boston, MA), 1 pl of neuraminidase (10 mu) (Nacalai Tesque), and 1.25 pl of 0-glycanase (1 mu) (Genzyme). After incubation at 37°C for 20 hr, the reaction was stopped by adding 47 pl of 2% SDS solution containing 2% 2-mercaptoethanol (Nacalai Tesque), followed by heating in a boiling water bath for 5 min. For control, the glycosidases were denatured by heating before adding to the incubation medium.
After SDS-PAGE, the bacterial lysates and the deglycosylated enzyme were electroblotted onto a nitrocellulose membrane (Towbin et al., 1979) in a buffer containing 25 mM Xis, 192 mM glycine, 0.02% SDS, and 10% methanol for 3 hr at 200 mA/25-30 V. Immunostaining of the membrane was performed as stated above, except that the membrane was incubated with 10 pg/ml GTL2 in NGS-BSA-Twen-PBS instead of culture medium at 4°C overnight.
Coomassie brilliant blue for protein staining of the gel and molecular weight markers were purchased from Pharmacia.
Immunohistochemistry. From seven male Wistar rats (8-16 weeks old) under deep anesthesia with diethylether, livers, epididymides, and submandibular, parotid, and sublingual glands were dissected out into icecold PBS and minced into small pieces. The following immunostaining procedures were performed on ice or at 4'C unless otherwise cited. The pieces were immediately fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 4 hr.
In a preliminary experiment, we also tested acetone and periodate-lysine-paraformaldehyde (PLP) fixative (McLean and Nakane, 1974) for indirect immunoperoxidase staining with GTU. Acetone fixation resulted not only in the strongest staining but also in the worst preservation of tissue structures. Both staining intensity and morphological preservation obtained by PLP fixative were intermediate between those by acetone and 4% paraformaldehyde. The glutaraldehyde-containing fixative drastically decreased staining intensity. Therefore, in the present study, 4% paraformaldehyde fixative, which properly preserved both the staining intensity and structures, was used.
The fixed tissues were carried through 5%. lo%, 15%, 20% sucrose in PBS for 3 hr each, and finally immersed in 20% sucrose containing 50%
OCT compound (Lab Tek Naperville, IL) in PBS overnight, and then rapidly frozen in liquid nitrogen. The frozen tissues were sectioned at 5-10pm with a cryostat and dried on glass slides. The sections were sequentially treated with 50 mM ammonium chloride in PBS three times for 10 min, rinsed with PBS containing 10% NGS and 1% BSA (NGS-BSA-PBS) for 1 hr, and then incubated with GTL2 (10 pglml of NGS-BSA-PBS) overnight. After four rinses with PBS for 10 min each, the sections were immersed in HRP-conjugated secondary antibody (see above) in NGS-BSA-PBS for 4 hr. After washing with PBS, the sections were briefly fixed in 1% glutaraldehyde in PBS for 10 min. After four rinses with PBS for 5 min each, the sections were treated with Graham-Karnovsky medium (Graham and Karnovsky, 1966) without H202 for 30 min and then with complete Graham-Kamovsky medium containing 0.003% H202 for 7 min at room temperature. The sections were either counterstained with methyl green and processed for light microscopic examination or post-fixed with 1% os04 in 0.1 M sodium cacodylate buffer (pH 7.4) containing 1% potassium ferrocyanide (Brown and Farquhar, 1989 ) dehydrated through a graded series of ethanol, and embedded in Epon for electron microscopic examination as reported previously (Suganuma et al., 1991) . As controls, the sections were treated with normal mouse IgG (10 pg/ml) instead of GTL2. These observations were performed on at least five sections per each tissue from each animal.
Results

Production of a Protein-specz$c W b , Gn2
GTL2 was raised against galactosyltransferase purified from rat liver microsomes and selected by screening for the MAb showing the highest reactivity to periodate-treated antigen. GTL2 was determined to be IgG2b by a subcIass typing kit. GTL2 c a d only 14% inhibition of galactosyltransferase activity.
Protein and antigen specificities of GTL2 were verified by two kinds of immunoblot analyses. One was performed using nonglycosylated recombinant proteins of human and mouse galactosyltransferases. GTL2 recognized only a single band of the human protein with a molecular weight of 38.000 (Figure 1. Lane 3) . but neither the mouse protein (Figure 1, Lane 4) nor other bands of crude bacterial lysates. In the other immunoblotting. purified rat galactosyltransferase was used after deglycosylation with glycosidases ( Figure 2 ). GTL2 specifically recognized asingle broad band of glycosidase-treated (Figure 2. Lane 2) or non-treated galactosyltransferase (Figure 2. Lane I), but no bands of glycosidases. The band of the non-treated enzyme was found around a molecular wight of 53,000 (Figure 2. Lane I), the same as that of the intact purified enzyme ( Kawano et al., 1992) , whereas the band of the treated enzyme was from 43.000 to 47.000 (Figure 2. Lane 2). The latter immunoblotting implies that the treated enzyme was successfully but not completely deglycosylated. since a fulllength polypeptide of galactosyltransferase is estimated to have a molecular weight of about 43.000 by the mouse cDNA sequence (Nakazawa et al., 1988; Shaper et al., 1988) . 
Immunohistochemical Study with GIZ2
By the immunoperoxidase method with G n Z , Iodization ofgalactosyltransferasc was studied in rat liver, epididymis, and salivary glands. Control experiments showed no or negligible staining (Figures 3b, 4b, and 5b) . In liver. specific reaction was detected in hepatocytes as small rod-shaped profiles at the light microscopic level (Figure 3a ). Kupffer (Figure 3a ) and endothelial cells (data not shown) were also stained. Immunoelectron microscopy showed that staining was localized in tram-Golgi cistems (Figure 3c ). In epididymis, supranuclear Golgi regions of epididymal duct epithelium were much more densely stained (Figure 4a ). GTL2 could not detect galactosyltransferase of spermatozoa in the ducts (Figure 4a) . The reaction was also localized in trans-Golgi cistems of epithelial cells (Figure 4c) .
In submandibular gland, intense staining was detected in serous cells but not in duct epithelium (Figure sa) . Intercalated d u m were only faintly stained (Figure 5a ). No immunostaining was detected in mast cells ( Figure >E) . In parotid gland, on the contrary, serous cells showed negligible staining but intercalated duct showed a relatively strong reaction (Figure 5d ). In sublingual gland, cytoplasm of mucous acinar cells was strongly stained, whereas d u m were weakly stained (Figure 5e ). Electron microscopic examination revealed that trum-Golgi lamelac of submandibular gland acinar cells were stained by GTL.2 (Figure 5f ). 
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We have produced GTL2, a new protein-specific MAb to rat gdactosyltransferase. G~Z specifically a mombinmt proof human dactosyltmsfem. including a C-terminal hdf of the stem region and a whole sequence of the catalytic region, but shows no reactivity to a mouse recombinant protein similarly prepared (Figure 1 ). Since the recombinant protein is nonglycosylated, GTL2 does not recognize carbohydrate chains but rather a polypeptide stnicture. In addition, GTL.2 could not severely inhibit enzyme activity of rat galactosyltransferase. These results suggest that the epitope exists not in the catalytic region but in the stem region, which shows the lowest degree of homology between human and mouse proteins.
In an LM immunohistochemical study with GTL.2, the strongest staining was observed in epididymal duct epithelial cells (Figure 4a ) and submandibular serous cells (Figure sa) . Hepatocytes showed less intense staining than these cells (Figure 3a) . These findings agree with previous biochemical studies showing that galactosyltransferase activity in submandibular gland or epididymis is much higher than in liver (Humphreys-Beher, 1984; Tadolini et al., 1977) . However, contradictory results were obtained in parotid and sublingual glands. Although enzyme activities in these salivary glands were almost identical to each other and were lower than in liver (Humphreys-Beher, 1984) . immunohistochemical staining with GTL.2 in sublingual gland ( Figure Se ) apparently seemed to be stronger than that of liver (Figure 3a) . Although in parotid gland relatively intense staining was observed in intercalated ducts (Figure 5d) . the entire immunoreactivity of parotid gland appeared to be less intense than that of sublingual gland. Interference of the enzyme assay by pyrophosphatase and phosphatase in tissue homogenates (Faltynek et al., 1981; Lau and Carlson, 1981 ) may explain these discrepancies.
It should be noted that intercalated ducts were more intensely stained by GTL.2 than serous acini in parotid gland (Figure 5d ). Since in parotid gland only intercalated ducts are strongly stained by a lectin-peroxidase method with Lotus tetragonofobus lectin (Schulte and Spicer, 1984) , the ducts may actively produce glycoproteins different from those mainly synthesized in acinar cells. The abundance of galactosyltransferase in intercalated ducts may be involved in this active synthesis.
A diformazan-linked coupled-enzyme technique has been developed to visualize galactosyltransferase activity in rat liver and submandibular gland (Benau et al., 1990) . The immunohistochemical localization presented here partially corresponds with the distribution patterns obtained from this enzyme histochemical method, although we could not detect immunohistochemical staining in mast cells that were intensely stained by the enzyme histochemical method. In mast cells, there may be another type of galactosyltransferase that GTL.2 cannot recognize.
The immunoelecuon microscopic study revealed that GTL.2 recognized only huns-Golgi membranes (Figures 3c, 4c, and 5f ). We could not detect GTL2 binding on the cell membranes. Biochemical studies have revealed that the cell surface expression of galactosyluansferase is much less than the Golgi expression in rat parotid gland (Marchase et al., 1988) as well as in other tissues and cells (Hathaway and Shur, 1992; Miller et al., 1992; Pierce et al., 1980; Roseman, 1970) . We have also confirmed the cell membrane localization of galactosyltransferase by immunohistochemical staining with a protein-specific MAb, GTF4 (Suganuma et al., 1991) . Since GTL2 and GTF4 are respectively IgG and IgM, GTF4 may be more sensitive than GTL.2 on the basis of antigenic valency but less advantageous in permeating through the cell membrane on the basis of molecular weight. This may be the reason why GTL.2 can detect the Golgi enzyme more clearly than GTF4 but cannot demonstrate the cell surface enzyme, which can be easily visualized by GTF4. However, there is the possibility that GTL2 recognizes a specific structure of the Golgi enzyme that does not exist in the cell surface enzyme.
Golgi and cell surface enzymes have been suggested to differ in structure by differential regulations of their enzyme-levels (Lopez et al., 1991; Marchase et al., 1988) and by the existence of short and long classes of galactosyltransferase "As, respectively encoding short and long forms of the enzyme proteins that differ only in the length of 13 amino acids at the amino terminal (Shaper et al., 1988) . Lopez et al. (1991) showed that the relative abundance of short and long "As correlated with enzyme activities in Golgi and cell surface enzymes, respectively, and proposed a hypothesis that short and long enzyme proteins were respectively targeted to Golgi and cell surface membranes. An amino-terminal amino acid sequencing (Kawano et al., 1992) has shown that the Golgi enzyme purified from rat liver is identical to the short protein, with the exception of one amino acid residue (Ala13) which is longer than that of the short protein, suggesting that most of the Golgi enzyme is produced by removal of the amino-terminal sequence from the long protein translated from the long "A.
Further investigation of the GTL2-binding epitope is required.
